Evidence map›Paper›PMID 41291222›Full record

Articlenpj antimicrobials and resistance2025

Molecular insights into silver nanoparticle resistance in Acinetobacter baumannii and unique adaptations to ionic silver.

Oliver McNeilly, Daniel G Mediati, Matthew J Pittorino, Riti Mann, Bill Söderström, Mehrad Hamidian, Cindy Gunawan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Revisiting the Fight AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oliver McNeilly *Australian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Daniel G MediatiAustralian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Matthew J PittorinoAustralian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Riti MannAustralian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Bill SöderströmAustralian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Mehrad HamidianAustralian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia. mehrad.hamidian@uts.edu.au.
Cindy Gunawan *Australian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia. cindy.gunawan@uts.edu.au.

Funding

Australian Research Council DP180100474Australian Research Council FT230100062
6 · The paper itself

Abstract

This research provides molecular insights into the evolutionarily adapted defense mechanisms of a bacterial pathogen against the complex antimicrobial activity of silver nanoparticles at the transcriptional level. The Gram-negative, biofilm-forming bacterium Acinetobacter baumannii upregulated outer membrane proteins along with genes involved in membrane and capsule synthesis, suggestive of enhanced cell surface defense. An increase in surface-attached biofilm colonies in nanosilver-resistant A. baumannii (NAg

Identifiers

PMID41291222
PMCPMC12647597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.